Abstract
Four separate laboratories performed antimicrobial susceptibility tests with 40 Haemophilus influenzae isolates, each tested in triplicate. Erythromycin and a new macrolide, clarithromycin (A-56268; TE-031), were tested by the disk diffusion method, by the agar dilution procedure in two different media, and by broth microdilution tests in four different media. Erythromycin MICs for 90% of the strains were 16 micrograms/ml in Mueller-Hinton broth with 3% lysed horse blood and NAD, 4.0 micrograms/ml in hemophilus test medium, and 2.0 micrograms/ml in supplemented Schaedler broth or in the fastidious broth medium from Beckman Instruments, Inc. Clarithromycin MICs were generally 1 doubling dilution greater than erythromycin MICs in each of the media. Erythromycin disk tests corresponded best with MICs determined in the fastidious broth medium. In that same medium, clarithromycin MICs were about 1 doubling dilution greater than what would be expected from the results of disk tests. Because there were fewer growth failures, hemophilus test medium is recommended for microdilution tests with H. influenzae. Incubation of all tests for a full 24 h without an increased CO2 atmosphere was needed to achieve maximal precision of the tests. Interlaboratory and intralaboratory reproducibility of all tests was satisfactory.
MeSH Terms
Clarithromycin
Culture Media
Erythromycin/analogs & derivatives,pharmacology
Haemophilus influenzae/drug effects,growth & development
Microbial Sensitivity Tests/methods
Chemicals
Culture Media
Erythromycin
Clarithromycin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Barry A L
Clinical Microbiology Institute, Tualatin, Oregon 97062.
Fernandes P B
Jorgensen J H
Thornsberry C
Hardy D J
Jones R N
References (12)
12 references, click to expand
-
Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli.
Appl Microbiol. 1970 Nov;20(5):754-6
PMID: 4991920
-
Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
J Clin Microbiol. 1986 Aug;24(2):233-9
PMID: 3091634
-
Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria.
J Clin Microbiol. 1986 Nov;24(5):701-4
PMID: 3095368
-
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
Antimicrob Agents Chemother. 1986 Dec;30(6):865-73
PMID: 2949695
-
Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
J Antimicrob Chemother. 1987 Jan;19(1):49-58
PMID: 3494009
-
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
J Clin Microbiol. 1987 Nov;25(11):2105-13
PMID: 3500965
-
Disk diffusion and disk elution tests with A-56268 and erythromycin.
Eur J Clin Microbiol. 1987 Feb;6(1):109-11
PMID: 2952500
-
Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031).
J Clin Microbiol. 1987 Jun;25(6):1079-82
PMID: 2954995
-
In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.
Antimicrob Agents Chemother. 1987 Apr;31(4):640-2
PMID: 2955742
-
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.
Antimicrob Agents Chemother. 1987 Aug;31(8):1243-50
PMID: 2957954
-
Comparative in vitro activity of A-56268 against respiratory tract pathogens.
Eur J Clin Microbiol. 1987 Aug;6(4):494-6
PMID: 2959474
-
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
Antimicrob Agents Chemother. 1987 Feb;31(2):343-5
PMID: 2952064